Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

VCEL

+ Watchlist+ Portfolio

Vericel Corp.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$57.88
52-Week Range
$28.95 – $59.75
Market Cap
$2.99B
P/E (TTM)
91.64
EPS (TTM)
0.64
Dividend Yield
0.00%
Advanced Metrics
Price/Book
7.79
PEG Ratio
—
Return on Equity
9.44%
Return on Assets
3.47%
Gross Margin
74.47%
Operating Margin
8.32%
Profit Margin
10.27%
Current Ratio
5.13
Debt/Equity
0.24
Total Debt
$91.15M
Free Cash Flow
$49.89M
Revenue Growth
26.50%
Earnings Growth
170.00%
Enterprise Value
$2.91B

Market Snapshot

About

Vericel Corp. is a leader in advanced therapies for the sports medicine and severe burn care markets. The company commercializes autologous cell therapy products including MACI for cartilage repair and Epicel for severe burns.